GOLDMAN SACHS GROUP INC - ABEONA THERAPEUTICS INC ownership

ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 54 filers reported holding ABEONA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ABEONA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$127,000
-75.3%
113,189
-65.7%
0.00%
Q2 2021$515,000
+104.4%
329,538
+145.3%
0.00%
Q1 2021$252,000
+227.3%
134,359
+173.9%
0.00%
Q4 2020$77,000
-67.8%
49,051
-79.1%
0.00%
Q3 2020$239,000
-63.3%
234,372
+4.7%
0.00%
Q2 2020$652,000
+0.5%
223,798
-27.6%
0.00%
Q1 2020$649,000
-28.8%
309,192
+11.0%
0.00%
Q4 2019$911,000
+63.8%
278,565
+13.2%
0.00%
Q3 2019$556,000
+50.7%
246,167
+218.5%
0.00%
Q2 2019$369,000
-5.9%
77,281
+45.3%
0.00%
Q1 2019$392,000
+28.9%
53,197
+25.1%
0.00%
Q4 2018$304,000
-56.1%
42,507
-21.3%
0.00%
Q3 2018$692,000
+166.2%
54,043
+232.3%
0.00%
Q2 2018$260,000
-80.9%
16,262
-82.8%
0.00%
Q1 2018$1,359,000
-1.1%
94,660
+9.2%
0.00%
Q4 2017$1,374,000
-43.9%
86,696
-39.6%
0.00%
-100.0%
Q3 2017$2,449,000
+3501.5%
143,625
+1256.1%
0.00%
Q2 2017$68,000
-88.3%
10,591
-90.9%
0.00%
Q1 2017$580,000
+900.0%
116,000
+869.7%
0.00%
Q4 2016$58,000
-85.9%
11,962
-82.5%
0.00%
Q3 2016$411,000
+902.4%
68,452
+290.2%
0.00%
Q2 2016$41,000
+32.3%
17,545
+44.7%
0.00%
Q1 2016$31,000
-58.7%
12,129
-45.4%
0.00%
Q4 2015$75,00022,2210.00%
Other shareholders
ABEONA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,215,740$709,0000.44%
AIGH Capital Management LLC 5,025,100$1,583,0000.39%
Worth Venture Partners, LLC 1,244,774$392,0000.18%
Kore Private Wealth LLC 154,637$49,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 8,007,272$2,522,0000.01%
Point72 Asset Management, L.P. 3,200,000$1,008,0000.00%
Cedar Brook Financial Partners, LLC 55,000$17,0000.00%
WealthTrust Axiom LLC 19,000$5,0000.00%
Phoenix Holdings Ltd. 296,872$91,0000.00%
IFP Advisors, Inc 10,000$175,0000.00%
View complete list of ABEONA THERAPEUTICS INC shareholders